| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $410K | — |
| R&D Expense | $6.7M | -1.5% |
| SG&A Expense | $6.2M | +12.4% |
| Operating Income | -$13.3M | -4.8% |
| Pre-tax Income | -$12.0M | -8.6% |
| Income Tax | $6K | +8.3% |
| Net Income | -$12.0M | -8.6% |
| EPS (Basic) | -$0.24 | -4.3% |
| EPS (Diluted) | -$0.24 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $30.8M | -23.7% |
| Current Assets | $31.0M | -24.5% |
| Total Assets | $45.6M | -18.4% |
| Current Liabilities | $3.8M | +28.3% |
| Total Liabilities | $4.0M | +19.1% |
| Stockholders' Equity | $41.6M | -20.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$9.8M | +7.8% |
| Capital Expenditures | $3K | +223.9% |
| Investing Cash Flow | -$3K | -315.9% |
| Financing Cash Flow | $244K | — |
| Free Cash Flow | -$9.8M | +7.8% |
| -4.3% |